SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $526,000 | -44.6% | 2,021,728 | +313.4% | 0.01% | -25.0% |
| Q1 2015 | $949,000 | -28.4% | 489,053 | -2.2% | 0.01% | -42.9% |
| Q4 2014 | $1,325,000 | -12.0% | 500,000 | 0.0% | 0.01% | -26.3% |
| Q3 2014 | $1,505,000 | -26.4% | 500,000 | 0.0% | 0.02% | -24.0% |
| Q2 2014 | $2,045,000 | -5.1% | 500,000 | 0.0% | 0.02% | -7.4% |
| Q1 2014 | $2,155,000 | -17.7% | 500,000 | 0.0% | 0.03% | -27.0% |
| Q4 2013 | $2,620,000 | -17.0% | 500,000 | 0.0% | 0.04% | -17.8% |
| Q3 2013 | $3,155,000 | -54.8% | 500,000 | -64.3% | 0.04% | -67.4% |
| Q2 2013 | $6,981,000 | – | 1,399,040 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |